Loading clinical trials...
Loading clinical trials...
Newer Direct-Acting Anti-Viral Agents as Sole Therapy of Porphyria Cutanea Tarda in Subjects With Chronic Hepatitis C
Conditions
Interventions
Harvoni
Locations
3
United States
University of California, San Francisco
San Francisco, California, United States
Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States
University of Texas Medical Branch
Galveston, Texas, United States
Start Date
September 6, 2017
Primary Completion Date
March 4, 2022
Completion Date
March 4, 2022
Last Updated
July 3, 2023
NCT06953479
NCT04162938
NCT03135886
NCT05968573
NCT01644903
NCT05042544
Lead Sponsor
Wake Forest University Health Sciences
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions